Interleukin-6 in Serum and in Synovial Fluid Enhances the Differentiation between Periprosthetic Joint Infection and Aseptic Loosening
Open Access
- 21 February 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (2), e89045
- https://doi.org/10.1371/journal.pone.0089045
Abstract
The preoperative differentiation between septic and aseptic loosening after total hip or knee arthroplasty is essential for successful therapy and relies in part on biomarkers. The objective of this study was to assess synovial and serum levels of inflammatory proteins as diagnostic tool for periprosthetic joint infection and compare their accuracy with standard tests. 120 patients presenting with a painful knee or hip endoprosthesis for surgical revision were included in this prospective trial. Blood samples and samples of intraoperatively acquired joint fluid aspirate were collected. White blood cell count, C-reactive protein, procalcitonin and interleukin-6 were determined. The joint aspirate was analyzed for total leukocyte count and IL-6. The definite diagnosis of PJI was determined on the basis of purulent synovial fluid, histopathology and microbiology. IL-6 in serum showed significantly higher values in the PJI group as compared to aseptic loosening and control, with specificity at 58.3% and a sensitivity of 79.5% at a cut-off value of 2.6 pg/ml. With a cut-off >6.6 pg/ml, the specificity increased to 88.3%. IL-6 in joint aspirate had, at a cut-off of >2100 pg/ml, a specificity of 85.7% and sensitivity of 59.4%. At levels >9000 pg/ml, specificity was almost at 100% with sensitivity just below 50%, so PJI could be considered proven with IL-6 levels above this threshold. Our data supports the published results on IL-6 as a biomarker in PJI. In our large prospective cohort of revision arthroplasty patients, the use of IL-6 in synovial fluid appears to be a more accurate marker than either the white blood cell count or the C-reactive protein level in serum for the detection of periprosthetic joint infection. On the basis of the results we recommend the use of the synovial fluid biomarker IL-6 for the diagnosis of periprosthetic joint infection following total hip and knee arthroplasty.Keywords
This publication has 30 references indexed in Scilit:
- New Definition for Periprosthetic Joint Infection: From the Workgroup of the Musculoskeletal Infection SocietyClinical Orthopaedics & Related Research, 2011
- Serological markers can lead to false negative diagnoses of periprosthetic infections following total knee arthroplastyInternational Orthopaedics, 2010
- Combining C-reactive Protein and Interleukin-6 May Be Useful to Detect Periprosthetic Hip InfectionClinical Orthopaedics and Related Research, 2010
- Synovial Fluid Biomarkers for Periprosthetic InfectionClinical Orthopaedics and Related Research, 2010
- Inflammatory response in 85 patients with loosened hip prostheses: A prospective study comparing inflammatory markers in patients with aseptic and septic prosthetic looseningActa Orthopaedica, 2007
- Interleukin-6, procalcitonin and TNF-αThe Journal of Bone and Joint Surgery. British volume, 2007
- Preoperative Evaluations in Revision Total Knee ArthroplastyClinical Orthopaedics and Related Research, 2006
- Proposal for a histopathological consensus classification of the periprosthetic interface membraneJournal of Clinical Pathology, 2006
- Prosthetic-Joint InfectionsThe New England Journal of Medicine, 2004
- Infection in Total Knee ReplacementPublished by Ovid Technologies (Wolters Kluwer Health) ,2001